Impaired Epidermal Permeability Barrier in Mice Lacking Elovl1, the Gene Responsible for Very-Long-Chain Fatty Acid Production

REFERENCES

• Proksch E, Brandner JM, Jensen JM. 2008. The skin: an indispensable barrier. Exp. Dermatol. 17:1063–1072.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Mitsutake S, Tsuji K, Kihara A, Igarashi Y. 2009. Ceramide biosynthesis in keratinocyte and its role in skin function. Biochimie 91:784–790.
   PubMed Web of Science ®Google Scholar
• Uchida Y, Holleran WM. 2008. Omega-O-acylceramide, a lipid essential for mammalian survival. J. Dermatol. Sci. 51:77–87.
   PubMed Web of Science ®Google Scholar
• Kihara A, Mitsutake S, Mizutani Y, Igarashi Y. 2007. Metabolism and biological functions of two phosphorylated sphingolipids, sphingosine 1-phosphate and ceramide 1-phosphate. Prog. Lipid Res. 46:126–144.
   PubMed Web of Science ®Google Scholar
• Aldahmesh MA, Mohamed JY, Alkuraya HS, Verma IC, Puri RD, Alaiya AA, Rizzo WB, Alkuraya FS. 2011. Recessive mutations in ELOVL4 cause ichthyosis, intellectual disability, and spastic quadriplegia. Am. J. Hum. Genet. 89:745–750.
   PubMed Web of Science ®Google Scholar
• Cameron DJ, Tong Z, Yang Z, Kaminoh J, Kamiyah S, Chen H, Zeng J, Chen Y, Luo L, Zhang K. 2007. Essential role of Elovl4 in very long chain fatty acid synthesis, skin permeability barrier function, and neonatal survival. Int. J. Biol. Sci. 3:111–119.
   PubMedGoogle Scholar
• Eckl KM, Tidhar R, Thiele H, Oji V, Hausser I, Brodesser S, Preil ML, Onal-Akan A, Stock F, Muller D, Becker K, Casper R, Nurnberg G, Altmuller J, Nurnberg P, Traupe H, Futerman AH, Hennies HC. Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J. Invest. Dermatol., in press.
   Google Scholar
• Jennemann R, Rabionet M, Gorgas K, Epstein S, Dalpke A, Rothermel U, Bayerle A, van der Hoeven F, Imgrund S, Kirsch J, Nickel W, Willecke K, Riezman H, Grone HJ, Sandhoff R. 2011. Loss of ceramide synthase 3 causes lethal skin barrier disruption. Hum. Mol. Genet. 21:586–608.
   PubMedGoogle Scholar
• Kihara A. 2012. Very long-chain fatty acids: elongation, physiology and related disorders. J. Biochem. 152:387–395.
   PubMedGoogle Scholar
• Li W, Sandhoff R, Kono M, Zerfas P, Hoffmann V, Ding BC, Proia RL, Deng CX. 2007. Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice. Int. J. Biol. Sci. 3:120–128.
   PubMed Web of Science ®Google Scholar
• Vasireddy V, Uchida Y, Salem NJr, Kim SY, Mandal MN, Reddy GB, Bodepudi R, Alderson NL, Brown JC, Hama H, Dlugosz A, Elias PM, Holleran WM, Ayyagari R. 2007. Loss of functional ELOVL4 depletes very long-chain fatty acids (≥C28) and the unique ω-O-acylceramides in skin leading to neonatal death. Hum. Mol. Genet. 16:471–482.
   PubMed Web of Science ®Google Scholar
• Imokawa G, Abe A, Jin K, Higaki Y, Kawashima M, Hidano A. 1991. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin? J. Invest. Dermatol. 96:523–526.
   PubMed Web of Science ®Google Scholar
• Motta S, Monti M, Sesana S, Caputo R, Carelli S, Ghidoni R. 1993. Ceramide composition of the psoriatic scale. Biochim. Biophys. Acta 1182:147–151.
   PubMed Web of Science ®Google Scholar
• Motta S, Monti M, Sesana S, Mellesi L, Ghidoni R, Caputo R. 1994. Abnormality of water barrier function in psoriasis. Role of ceramide fractions. Arch. Dermatol. 130:452–456.
   PubMed Web of Science ®Google Scholar
• Di Nardo A, Wertz P, Giannetti A, Seidenari S. 1998. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm. Venereol. 78:27–30.
   PubMed Web of Science ®Google Scholar
• Bleck O, Abeck D, Ring J, Hoppe U, Vietzke JP, Wolber R, Brandt O, Schreiner V. 1999. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J. Invest. Dermatol. 113:894–900.
   PubMed Web of Science ®Google Scholar
• Janssens M, van Smeden J, Gooris GS, Bras W, Portale G, Caspers PJ, Vreeken RJ, Hankemeier T, Kezic S, Wolterbeek R, Lavrijsen AP, Bouwstra JA. 2012. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J. Lipid Res. 53:2755–2766.
   PubMed Web of Science ®Google Scholar
• Ohno Y, Suto S, Yamanaka M, Mizutani Y, Mitsutake S, Igarashi Y, Sassa T, Kihara A. 2010. ELOVL1 production of C24 acyl-CoAs is linked to C24 sphingolipid synthesis. Proc. Natl. Acad. Sci. U. S. A. 107:18439–18444.
   PubMed Web of Science ®Google Scholar
• Adams DJ, Quail MA, Cox T, van der Weyden L, Gorick BD, Su Q, Chan WI, Davies R, Bonfield JK, Law F, Humphray S, Plumb B, Liu P, Rogers J, Bradley A. 2005. A genome-wide, end-sequenced 129Sv BAC library resource for targeting vector construction. Genomics 86:753–758.
   PubMedGoogle Scholar
• Lee EC, Yu D, Martinez de Velasco J, Tessarollo L, Swing DA, Court DL, Jenkins NA, Copeland NG. 2001. A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA. Genomics 73:56–65.
   PubMed Web of Science ®Google Scholar
• Matsumura H, Hasuwa H, Inoue N, Ikawa M, Okabe M. 2004. Lineage-specific cell disruption in living mice by Cre-mediated expression of diphtheria toxin A chain. Biochem. Biophys. Res. Commun. 321:275–279.
   PubMedGoogle Scholar
• Hardman MJ, Sisi P, Banbury DN, Byrne C. 1998. Patterned acquisition of skin barrier function during development. Development 125:1541–1552.
   PubMed Web of Science ®Google Scholar
• Hauptmann G, Gerster T. 1994. Two-color whole-mount in situ hybridization to vertebrate and Drosophila embryos. Trends Genet. 10:266.
   PubMed Web of Science ®Google Scholar
• Caldelari R, Müller EJ. 2010. Short- and long-term cultivation of embryonic and neonatal murine keratinocytes. Methods Mol. Biol. 633:125–138.
   PubMedGoogle Scholar
• Sandhoff R. 2010. Very long chain sphingolipids: tissue expression, function and synthesis. FEBS Lett. 584:1907–1913.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Kihara A, Igarashi Y. 2005. Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 390:263–271.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Kihara A, Igarashi Y. 2006. LASS3 (longevity assurance homologue 3) is a mainly testis-specific (dihydro)ceramide synthase with relatively broad substrate specificity. Biochem. J. 398:531–538.
   PubMed Web of Science ®Google Scholar
• Laviad EL, Albee L, Pankova-Kholmyansky I, Epstein S, Park H, Merrill AHJr, Futerman AH. 2008. Characterization of ceramide synthase 2: tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate. J. Biol. Chem. 283:5677–5684.
   PubMed Web of Science ®Google Scholar
• Mizutani Y, Kihara A, Chiba H, Tojo H, Igarashi Y. 2008. 2-Hydroxy-ceramide synthesis by ceramide synthase family: enzymatic basis for the preference of FA chain length. J. Lipid Res. 49:2356–2364.
   PubMedGoogle Scholar
• Ofman R, Dijkstra IM, van Roermund CW, Burger N, Turkenburg M, van Cruchten A, van Engen CE, Wanders RJ, Kemp S. 2010. The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy. EMBO Mol. Med. 2:90–97.
   PubMed Web of Science ®Google Scholar